bioRxivMolecular BiologyPreprint
Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLD
Longxin XieiD, Yuehua Zhu, Bryan T. Hurtle, Matthew WrightiD, John L. RobinsoniD, Jocelyn C. MaunaiD, Emily E. Brown, Marilyn Ngo, Cristian A BergmanniD, Jiazhen XuiD, Jessica MerjaneiD, Amanda M. GleixneriD, Gabriela GrigoreaniD, Feilin LiuiD, Wilfried RossolliD, Edward B. LeeiD, Evangelos KiskinisiD, Maria D. ChikinaiD, Christopher J. DonnellyiD
Abstract
TDP-43 mislocalization, aggregation, and loss of splicing function are neuropathological hallmarks in over 97% of Amyotrophic Lateral Sclerosis (ALS), 45% of Frontotemporal Lobar Degeneration (FTLD), and 60% of Alzheimers Disease, which has been reclassified as LATE-NC. However, the mechanisms underlying TDP-43 dysfunction remain elusive. Here, we utilize APEX2-driven proximity labeling and mass spectrometry to characterize the context-dependent TDP-43 interactome in conditions of cytoplasmic mislocalization, impaired RNA-binding contributing to aggregation, and oxidative stress. We describe context-dependent interactors, including disrupted interactions with splicing-related proteins and altered biomolecular condensate (BMC) associations. By integrating ALS and FTLD snRNA-seq data, we uncover disease-relevant molecular alterations and validate our dataset through a functional screen that identifies key TDP- 43 regulators. We demonstrate that disrupting nuclear speckle integrity, particularly through the downregulation of the splicing factor SRRM2, promotes TDP-43 mislocalization and loss of function. Additionally, we identify NUFIP2 as an interactor associated with mislocalization that sequesters TDP-43 into cytoplasmic aggregates and co-localizes with TDP-43 pathology in patient tissue. We also highlight HNRNPC as a potent TDP-43 splicing regulator, where precise modulation of TDP-43 or HNRNPC can rescue cryptic exon splicing. These findings provide mechanistic insights and potential therapeutic targets for TDP-43 dysfunction.
- organism: human
- assay: snRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 8
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TDP-43 toxic gain of function links ALS, FTD and Alzheimers Disease through splicing dysregulation
Welmoed van Zuiden, Thea Deborah Meimoun, … Eran Hornstein·bioRxiv·Apr 20, 2025
- Integrative multiomic analysis links TDP-43-driven splicing defects to cascading proteomic disruption of ALS/FTD pathways
Velina Kozareva, Zhengde Liu, … Sarah E. Kargbo-Hill·bioRxiv·Sep 29, 2025
- A panel of TDP-43-regulated splicing events verify loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue
Maize C. Cao, Brigid Ryan, … Emma L. Scotter·Neurobiology of DiseasePeer-reviewed·Jul 30, 2023
- Export-biased, 3'UTR-preserving TDP-43 model links nuclear loss to cytoplasmic aggregation in ALS/FTLD
Genri Toyama, Shingo Koide, … Akihiro Sugai·bioRxiv·Nov 12, 2025
- A functional interaction between TDP-43 and USP10 reveals USP10 dysfunction in TDP-43 proteinopathies
Alessandro Marrero‐Gagliardi, Judith Noda, … Abraham Acevedo‐Arozena·bioRxiv·Jan 23, 2024
- SFPQ dysregulation promotes TDP-43 pathology through a pathogenic feedback loop
Alison L. Hogan, Patrick Chiu, … Marco Morsch·bioRxiv·Jul 25, 2026